Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL

Franco Locatelli, Maria Grazia Valsecchi, Anja Möricke, Martin Zimmermann, Bernd Gruhn, Andrea Biondi, Andreas E Kulozik, Daniela Silvestri, Nicole Bodmer, Maria Caterina Putti, Stefan Burdach, Concetta Micalizzi, Andrea Teigler-Schlegel, Jörg Ritter, Andrea Pession, Gunnar Cario, Stefan Bielack, Giuseppe Basso, Thomas Klingebiel, Luciana VintiCarmelo Rizzari, Andishe Attarbaschi, Nicola Santoro, Rosanna Parasole, Georg Mann, Leonid Karawajew, Oskar A Haas, Valentino Conter, Martin Schrappe

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2146-2149
Number of pages4
JournalBlood
Volume130
Issue number19
DOIs
Publication statusPublished - Nov 9 2017

Keywords

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Remission Induction
  • Treatment Outcome
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

Cite this

Locatelli, F., Valsecchi, M. G., Möricke, A., Zimmermann, M., Gruhn, B., Biondi, A., Kulozik, A. E., Silvestri, D., Bodmer, N., Putti, M. C., Burdach, S., Micalizzi, C., Teigler-Schlegel, A., Ritter, J., Pession, A., Cario, G., Bielack, S., Basso, G., Klingebiel, T., ... Schrappe, M. (2017). Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL. Blood, 130(19), 2146-2149. https://doi.org/10.1182/blood-2017-05-782086